Follow the Vimian Group AB share price and the full insider trade history of the company, a listed equity based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Vimian Group AB has logged 2 public disclosures. Market capitalisation: €15.7bn. The latest transaction was disclosed on 14 January 2026 (Purchase). Among the most active insiders: Bart Bremer. The full history is accessible without an account.
Analysts rate Vimian Group AB Buy (bullish), based on 5 analysts. Average price target: SEK 34.87.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations